Reported Standalone quarterly numbers for Suven Life Sciences are:Net Sales at Rs 2.39 crore in March 2024 down 8.65% from Rs. 2.61 crore in March 2023.
Quarterly Net Loss at Rs. 3.12 crore in March 2024 down 38.88% from Rs. 2.25 crore in March 2023.
EBITDA stands negative at Rs. 2.59 crore in March 2024 down 388.68% from Rs. 0.53 crore in March 2023.
| Suven Life Sci shares closed at 99.15 on May 16, 2024 (NSE) and has given 20.33% returns over the last 6 months and 73.04% over the last 12 months. |
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 2.39 | 2.45 | 2.61 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 2.39 | 2.45 | 2.61 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.46 | 4.32 | 3.18 | | Depreciation | 1.51 | 1.60 | 1.67 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | 4.18 | 6.19 | 4.38 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.61 | 1.14 | 1.17 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -8.38 | -10.80 | -7.80 | | Other Income | 4.28 | 6.07 | 5.60 | | P/L Before Int., Excpt. Items & Tax | -4.10 | -4.73 | -2.20 | | Interest | 0.03 | 0.04 | 0.05 | | P/L Before Exceptional Items & Tax | -4.13 | -4.77 | -2.25 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -4.13 | -4.77 | -2.25 | | Tax | -1.00 | -- | -- | | P/L After Tax from Ordinary Activities | -3.12 | -4.77 | -2.25 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -3.12 | -4.77 | -2.25 | | Equity Share Capital | 21.81 | 21.81 | 21.81 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.14 | -0.22 | -0.05 | | Diluted EPS | -0.14 | -0.22 | -0.05 | | EPS After Extra Ordinary | | Basic EPS | -0.14 | -0.22 | -0.05 | | Diluted EPS | -0.14 | -0.22 | -0.05 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
